drugset / Trial / NCT06554054

A Study of GZR18 Tablet in Chinese Healthy Subjects

NCT06554054

Phase 1 Active not recruiting 92 enrolled Gan and Lee Pharmaceuticals, USA
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the trial is to investigate the the bioavailability, pharmacokinetics, pharmacodynamics, safety and tolerance of single and multiple doses of GZR18 tablet in healthy subjects.

Timeline

Start
2024-04-01
Primary completion
2024-12-09
Completion
2024-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bofanglutide Protein / enzyme biologic Oral